To perform metabolic analyses on cells expressing physiologically relevant levels of IDO1, we sought to evaluate the expression of IDO1/Ido1 in pancreatic cancer cells across a range of in vitro and in vivo contexts (Figure 1A). The gene discussed is IDO1; the disease is familial pancreatic carcinoma.